Trial Profile
A Randomised, Two-period, Two-sequence, Single-dose and Cross-over Study in Healthy Subjects to Demonstrate Pharmacokinetic Equivalence of Altebrel (Produced by Aryogen Pharmed) and Enbrel® (the Reference Drug, Produced by Amgen Company)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Adalimumab
- Indications Ankylosing spondylitis; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AryoGen Pharmed
- 08 Sep 2017 New trial record